The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Antiparasitic Drugs Market Expected To Change Between 2026 And 2030?
The antiparasitic drugs market has experienced substantial expansion in recent years. This market is anticipated to expand from $25.58 billion in 2025 to $27.18 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.2%. The growth observed in previous periods is attributable to the increasing prevalence of parasitic diseases, limited access to modern antiparasitic drugs in developing regions, traditional reliance on monotherapy drugs, rising veterinary care demand, and a lack of awareness regarding preventive measures.
The antiparasitic drugs market size is projected to experience substantial growth in the upcoming years. It is expected to expand to $36.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This projected growth can be attributed to several factors during the forecast period, including the increasing adoption of combination therapy, advancements in precision medicine for parasitic infections, a heightened focus on animal health and livestock protection, the expansion of emerging markets, and the development of innovative delivery systems for antiparasitic drugs. Significant trends anticipated in this period encompass the rising occurrence of parasitic infections, the creation of combination antiparasitic drugs, the broadening of animal healthcare applications, an increase in preferences for oral and injectable treatments, and the emergence of new antiparasitic agents.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp
Which Economic Or Industry Drivers Are Impacting The Antiparasitic Drugs Market?
The rising prevalence of vector-borne illnesses is anticipated to boost the expansion of the antiparasitic drugs market in the future. These are infectious conditions spread to humans or animals via the bites of arthropods, mainly insects such as mosquitoes, ticks, and flies. Malaria, dengue, and yellow fever are a few instances of such diseases. Antiparasitic drugs are crucial for halting the transmission of vector-borne diseases by targeting and eradicating the causative parasites. Certain antiparasitic medications, like chloroquine, doxycycline, and atovaquone-proguanil, are frequently prescribed for malaria treatment. For example, data from the US-based Government agency, the Centers for Disease Control and Prevention, in June 2024, indicated that from January to June 2024, the Americas saw more than 9.7 million dengue cases, which is over twice the 4.6 million cases reported during 2023. Within the United States, Puerto Rico recorded 1,498 dengue cases, and an additional 745 cases were found among U.S. travelers returning from regions where the disease is prevalent. Consequently, the rising occurrence of vector-borne illnesses fuels the expansion of the antiparasitic drugs market.
How Is The Antiparasitic Drugs Market Structured Across Different Segments?
The antiparasitic drugs market covered in this report is segmented –
1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Imidazolesthiazoles
3) By Route of Administration: Oral, Injectable, Topical
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel
2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine
3) By Ectoparasiticides: Permethrin, Malathion, Fipronil
4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents
Which Trends Are Shaping The Future Of The Antiparasitic Drugs Market?
Leading companies active in the antiparasitic drugs market are concentrating on developing innovative products, such as chewable veterinary items, to enhance ease of administration and improve pet cooperation with treatment. Chewable veterinary products are flavored, simple-to-administer tablets or treats designed for delivering medication to animals. They improve pet compliance by making the treatment experience more palatable and less stressful. For example, in April 2024, C.H. Boehringer Sohn AG and Co. KG, a Germany-based pharmaceutical company, launched NexGard Spectra to offer comprehensive parasite control. NexGard SPECTRA is a soft, flavorful chew that provides complete internal and external parasite control for dogs, effectively targeting fleas, ticks, heartworms, and various intestinal worms with a single monthly dose. It demonstrates rapid action, killing fleas within four hours of administration and achieving over 99% effectiveness against multiple parasites shortly thereafter.
Which Major Players Dominate The Antiparasitic Drugs Market?
Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim Group, Zoetis Inc., Eisai Co. Ltd., Dr. Reddy’s Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Santé Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier
Read the full antiparasitic drugs market report here:
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
What Are The Top-Performing Regions Within The Antiparasitic Drugs Market?
North America was the largest region in the antiparasitic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antiparasitic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Antiparasitic Drugs Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12927&type=smp
Browse Through More Reports Similar to the Global Antiparasitic Drugs Market 2026, By The Business Research Company
Antiparasitic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
Antispasmodics Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report
Anticholinergic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model